Panagene Inc
KOSDAQ:046210
Intrinsic Value
PANAGENE Inc. engages in the molecular diagnostics business. [ Read More ]
The intrinsic value of one Panagene Inc stock under the Base Case scenario is 1 912.78 KRW. Compared to the current market price of 4 070 KRW, Panagene Inc is Overvalued by 53%.
Valuation Backtest
Panagene Inc
Run backtest to discover the historical profit from buying and selling Panagene Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Panagene Inc
Current Assets | 82.9B |
Cash & Short-Term Investments | 76.9B |
Receivables | 3B |
Other Current Assets | 3B |
Non-Current Assets | 8B |
PP&E | 7.3B |
Intangibles | 286.2m |
Other Non-Current Assets | 389.8m |
Current Liabilities | 27.1B |
Accounts Payable | 431.6m |
Accrued Liabilities | 161.2m |
Other Current Liabilities | 26.5B |
Non-Current Liabilities | 206.4m |
Long-Term Debt | 89.4m |
Other Non-Current Liabilities | 117m |
Earnings Waterfall
Panagene Inc
Revenue
|
12.3B
KRW
|
Cost of Revenue
|
-4B
KRW
|
Gross Profit
|
8.2B
KRW
|
Operating Expenses
|
-10.1B
KRW
|
Operating Income
|
-1.8B
KRW
|
Other Expenses
|
-3B
KRW
|
Net Income
|
-4.8B
KRW
|
Free Cash Flow Analysis
Panagene Inc
Profitability Score
Profitability Due Diligence
Panagene Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Panagene Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Panagene Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Panagene Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Panagene Inc
Shareholder Return
Price
Panagene Inc
Average Annual Return | 11.65% |
Standard Deviation of Annual Returns | 64.86% |
Max Drawdown | -74% |
Market Capitalization | 166.9B KRW |
Shares Outstanding | 41 014 500 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.
Contact
IPO
Employees
Officers
The intrinsic value of one Panagene Inc stock under the Base Case scenario is 1 912.78 KRW.
Compared to the current market price of 4 070 KRW, Panagene Inc is Overvalued by 53%.